Imaging atherosclerosis in the carotid arteries with F-18-fluoro-2-deoxy-D-glucose positron emission tomography: Effect of imaging time after injection on quantitative measurement

Nuclear Medicine and Molecular Imaging

Volumn 44, Issue 4, 2010, Pages 261-266

  Oh, Minyoung ^a   Kim, Ji Young ^a   Shin, Kwang Ho ^a   Park, Seol Hoon ^a   Ryu, Jin Sook ^a   Kim, Jae Seung ^a   Kim, Hye Jin ^a   Kang, Dong Wha ^a   Moon, Dae Hyuk ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Carotid arteries; F 18 FDG PET CT; Imaging time

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD POOL SCINTISCANNING; BLOOD VESSEL WALL; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; ISOTOPE TRACING; JUGULAR VEIN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION MEASUREMENT; SUPERIOR CAVA VEIN; WHOLE BODY TOMOGRAPHY;

EID: 79952740032     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-010-0043-y     Document Type: Article

References (21)

1. Davies MJ, Thomas AC (1985) Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53:363-373.
2. Izquierdo-Garcia D, Davies JR, Graves MJ, Rudd JH, Gillard JH, Weissberg PL et al (2009) Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke 40:86-93.
3. Aziz K, Berger K, Claycombe K, Huang R, Patel R, AbelaGS (2008) Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation117:2061-2070.
4. Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H et al (2005) Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12:294-301.
5. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A (2009) Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 36:144-151.
6. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N et al (2002) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105:2708-2711.
7. Davies JR, Rudd JH, Fryer TD, Graves MJ, Clark JC, Kirkpatrick PJ et al (2005) Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positronemission tomography and high-resolution magnetic resonance imaging. Stroke 36:2642-2647.
8. Menezes LJ, Kotze CW, Hutton BF, Endozo R, Dickson JC, Cullum I et al (2009) Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med 50:854-857.
9. Townsend DW (2008) Dual-modality imaging: combining anatomy and function. J Nucl Med 49:938-955.
10. Okane K, Ibaraki M, Toyoshima H, Sugawara S, Takahashi K, Miura S et al (2006) 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries. Eur J Nucl Med Mol Imaging 33:589-594.
11. Panin VY, Kehren F, Michel C, Casey M (2006) Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imaging 25:907-921.
12. Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M et al (2007) (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 50:892-896.
13. Rudd JH, Elkhawad M, Fayad ZA (2009) Vascular imaging with 18F-FDG PET/CT: optimal 18F-FDG circulation time? J Nucl Med 50:1560; author reply 1560-1561.
14. Wu YW, Kao HL, Chen MF, Lee BC, Tseng WY, Jeng JS et al (2007) Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 48:227-233.
15. Arauz A, Hoyos L, Zenteno M, Mendoza R, Alexanderson E (2007) Carotid plaque inflammation detected by 18Ffluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 109:409-412.
16. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC et al (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48:1818-1824.
17. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K et al (2006) Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48:1825-1831.
18. Tahara N, Kai H, Yamagishi S, Mizoguchi M, Nakaura H, Ishibashi M et al (2007) Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49:1533-1539.
19. Ogawa M, Magata Y, Kato T, Hatano K, Ishino S, Mukai T et al (2006) Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med 47:1845-1850.
20. Font MA, Fernandez A, Carvajal A, Gamez C, Badimon L, Slevin M et al (2009) Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Front Biosci 14:3352-3360.
21. So Y, Chung JK, Jeong JM, Lee DS, Lee MC (2005) Usefulness of additional delayed regional F-18 fluorodeoxy-glucose positron emission tomography in the lymph node staging of non-small cell lung cancer patients. Cancer Res Treat 37:114-121.